Cargando…

Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?

BACKGROUND: Altitude sojourns increasingly attract individuals of all ages and different health statuses due to the appeal of high-altitude destinations worldwide and easy access to air travel. The risk of acute mountain sickness (AMS) when flying to high-altitude destinations remains underemphasize...

Descripción completa

Detalles Bibliográficos
Autores principales: Burtscher, Johannes, Swenson, Erik R, Hackett, Peter H, Millet, Grégoire P, Burtscher, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289512/
https://www.ncbi.nlm.nih.gov/pubmed/36694981
http://dx.doi.org/10.1093/jtm/taad011
_version_ 1785062295929356288
author Burtscher, Johannes
Swenson, Erik R
Hackett, Peter H
Millet, Grégoire P
Burtscher, Martin
author_facet Burtscher, Johannes
Swenson, Erik R
Hackett, Peter H
Millet, Grégoire P
Burtscher, Martin
author_sort Burtscher, Johannes
collection PubMed
description BACKGROUND: Altitude sojourns increasingly attract individuals of all ages and different health statuses due to the appeal of high-altitude destinations worldwide and easy access to air travel. The risk of acute mountain sickness (AMS) when flying to high-altitude destinations remains underemphasized. Thus, this review aims to evaluate the altitude-dependent AMS incidence depending on the mode of ascending, e.g. by air vs terrestrial travel. METHODS: A literature search was performed to identify the observational studies assessing AMS incidence after acute ascent of primarily healthy adults to real high altitude. In addition, placebo arms of interventional trials evaluating the prophylactic efficacy of various drugs have been separately analysed to confirm or refute the findings from the observational studies. Linear regression analyses were used to evaluate the altitude-dependent AMS incidence. RESULTS: Findings of 12 observational studies, in which the AMS incidence in 11 021 individuals ascending to 19 different altitudes (2200–4559 m) was evaluated, revealed an impressive 4.5-fold steeper increase in the AMS incidence for air travel as compared with slower ascent modes, i.e. hiking or combined car and/or air travel and hiking. The higher AMS incidence following transportation by flight vs slower means was also confirmed in placebo-treated participants in 10 studies of drug prophylaxis against AMS. CONCLUSIONS: Due to the short time span in going from low to high altitude, reduced acclimatization likely is the main reason for a higher AMS risk when travelling to high-altitude destinations by flight. To avoid frustrating travel experiences and health risks, appropriate and timely medical advice on how to prepare for air travel to high altitude is of vital importance. Effective preparation options include the use of modern pre-acclimatization strategies and pharmacological prophylaxis by acetazolamide or dexamethasone, or even considering alternate itineraries with more gradual ascent.
format Online
Article
Text
id pubmed-10289512
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102895122023-06-24 Flying to high-altitude destinations: Is the risk of acute mountain sickness greater? Burtscher, Johannes Swenson, Erik R Hackett, Peter H Millet, Grégoire P Burtscher, Martin J Travel Med Review BACKGROUND: Altitude sojourns increasingly attract individuals of all ages and different health statuses due to the appeal of high-altitude destinations worldwide and easy access to air travel. The risk of acute mountain sickness (AMS) when flying to high-altitude destinations remains underemphasized. Thus, this review aims to evaluate the altitude-dependent AMS incidence depending on the mode of ascending, e.g. by air vs terrestrial travel. METHODS: A literature search was performed to identify the observational studies assessing AMS incidence after acute ascent of primarily healthy adults to real high altitude. In addition, placebo arms of interventional trials evaluating the prophylactic efficacy of various drugs have been separately analysed to confirm or refute the findings from the observational studies. Linear regression analyses were used to evaluate the altitude-dependent AMS incidence. RESULTS: Findings of 12 observational studies, in which the AMS incidence in 11 021 individuals ascending to 19 different altitudes (2200–4559 m) was evaluated, revealed an impressive 4.5-fold steeper increase in the AMS incidence for air travel as compared with slower ascent modes, i.e. hiking or combined car and/or air travel and hiking. The higher AMS incidence following transportation by flight vs slower means was also confirmed in placebo-treated participants in 10 studies of drug prophylaxis against AMS. CONCLUSIONS: Due to the short time span in going from low to high altitude, reduced acclimatization likely is the main reason for a higher AMS risk when travelling to high-altitude destinations by flight. To avoid frustrating travel experiences and health risks, appropriate and timely medical advice on how to prepare for air travel to high altitude is of vital importance. Effective preparation options include the use of modern pre-acclimatization strategies and pharmacological prophylaxis by acetazolamide or dexamethasone, or even considering alternate itineraries with more gradual ascent. Oxford University Press 2023-01-25 /pmc/articles/PMC10289512/ /pubmed/36694981 http://dx.doi.org/10.1093/jtm/taad011 Text en © International Society of Travel Medicine 2023. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Burtscher, Johannes
Swenson, Erik R
Hackett, Peter H
Millet, Grégoire P
Burtscher, Martin
Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?
title Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?
title_full Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?
title_fullStr Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?
title_full_unstemmed Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?
title_short Flying to high-altitude destinations: Is the risk of acute mountain sickness greater?
title_sort flying to high-altitude destinations: is the risk of acute mountain sickness greater?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289512/
https://www.ncbi.nlm.nih.gov/pubmed/36694981
http://dx.doi.org/10.1093/jtm/taad011
work_keys_str_mv AT burtscherjohannes flyingtohighaltitudedestinationsistheriskofacutemountainsicknessgreater
AT swensonerikr flyingtohighaltitudedestinationsistheriskofacutemountainsicknessgreater
AT hackettpeterh flyingtohighaltitudedestinationsistheriskofacutemountainsicknessgreater
AT milletgregoirep flyingtohighaltitudedestinationsistheriskofacutemountainsicknessgreater
AT burtschermartin flyingtohighaltitudedestinationsistheriskofacutemountainsicknessgreater